Sanofi-aventis having 85 years of innovation in the diabetes is committed to offering people with diabetes an integrated system of insulin products and delivery devices. In addition to the SoloSTAR®, the pen portfolio available for LANTUS® and APIDRA® includes the OptiSet® disposable pen, the OptiClik® and OptiPen® Pro reusable pens, and the Autopen® 24 from Owen Mumford.

Contact Information

174 Avenue De France
Paris, 75013

tel: 33 1 53 77 45 45
fax: 33 1 53 77 42 96


Investor Relations



Exchange: NYSE
Industry: Drug Manufacturers - Major
Market Cap: $111.7B

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.